Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jesús Ochoa is active.

Publication


Featured researches published by Jesús Ochoa.


Malaria Journal | 2005

Nosocomial Plasmodium falciparum infections confirmed by molecular typing in Medellín, Colombia.

Lina María González; Jesús Ochoa; Liliana Franco; Marta Arroyave; Eliana Restrepo; Silvia Blair; Amanda Maestre

Three cases of nosocomial malaria are reported from patients of the Internal Medicine Ward of a tertiary University teaching hospital in Medellin, Colombia. Epidemiological research, based on entomological captures, medical records review and interviews of nursery staff about patient care practices potentially involving contact with blood, were carried out. Molecular characterization of Plasmodium falciparum was based on the amplification of MSP1, MSP2 and GLURP genes. This method enabled confirmation of the same P. falciparum genotype in all three patients as well as in a fourth one (index case). The presence of nosocomial malaria was confirmed and it was concluded that the most likely source of transmission was through multi-dose preparations of heparin applied to heparin locks.


Tropical Medicine & International Health | 2017

Stratifying the potential local transmission of Zika in municipalities of Antioquia, Colombia

Juan Ospina; Doracelly Hincapie-Palacio; Jesús Ochoa; Adriana Molina; Guillermo Rúa; Dubán Pájaro; Marcela Arrubla; Rita Almanza; Marlio Paredes; Anuj Mubayi

To stratify and understand the potential transmission processes of Zika virus in Colombia, in order to effectively address the efforts on surveillance and disease control.


Vaccine | 2018

Effect of maternal immunization against pertussis in Medellin and the metropolitan area, Colombia, 2016–2017

Doracelly Hincapie-Palacio; María Cristina Hoyos; Jesús Ochoa; Nilton Edu Montoya; Diego García; Elkin Osorio

BACKGROUND In 2013, pertussis immunization (Tdap) for pregnant women was implemented in Colombia to protect newborns in response to increased pertussis incidence. OBJECTIVE To assess the effect of Tdap maternal immunization on the concentration of mother/umbilical cord antibodies and the occurrence of pertussis in infants during their first six months of life. METHODS A cohort study in eight randomly selected hospitals in Medellin and metropolitan area of Antioquia, Colombia was conducted in 2015-2016. IgG PT antibody levels in paired maternal and umbilical cord sera were measured from 805 mothers immunized recruited during labor and 200 mothers recruited during the prenatal care before immunization and followed until delivery. Antibodies were analyzed by commercial ELISA kits. 896 infants were followed to detect acute respiratory infections and paroxysms of coughing, inspiratory whoop, apnea, cyanosis or post-tussive vomiting. For laboratory confirmation, B. pertussis- specific real time PCR was performed. RESULTS We observed a high prevalence of titers >100 IU/mL (mother: 18.40% [95% CI 16-21%]; umbilical cord: 23.1% [95% CI 19.2-27.4%]), positive correlation of umbilical cord and maternal antibodies, higher antibody concentration in vaccinated than in non-vaccinated mothers and significant difference in antibody levels before and after vaccination (Wilcoxon test p = 0.000). The trans placental transport ratio was higher if the mother was vaccinated between 26 and 30 weeks of pregnancy and maximum eight weeks before delivery. Two cases of pertussis were confirmed in infants (incidence of 1.99 per 1000). CONCLUSION The expected effect of Tdap maternal vaccination against pertussis was observed.


American Journal of Tropical Medicine and Hygiene | 2016

Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital.

Diego H. Cáceres; Angela Tobón; Angela A. Cleveland; Christina M. Scheel; Dedsy Y. Berbesi; Jesús Ochoa; Angela Restrepo; Mary E. Brandt; Tom Chiller; Beatriz L. Gómez


Infectio | 2003

Enterococo resistente a vancomicina en un hospital universitario: características clínicas y epidemiológicas de 100 casos, 1998-2003

Sigifredo Ospina; Jaime Robledo; Lázaro A. Vélez; Luz Adriana Patiño; Jesús Ochoa; Liliana Franco


Facultad Nacional de Salud Pública | 2018

Concepción Antioquia, 1979

Jesús Ochoa


arXiv: Populations and Evolution | 2016

The reproductive number of Zika in municipalities of Antioquia, Colombia: stratifying the potential transmission of an ongoing epidemic

Juan Ospina; Doracelly Hincapie-Palacio; Jesús Ochoa; Adriana Molina; Guillermo Rúa; Dubán Pájaro; Marcela Arrubla; Rita Almanza; Marlio Paredes; Anuj Mubayi


Infectio | 2016

Surgical site infection after breast cancer surgery at 30 days and associated factors

Joana-Cristina Gil-Londoño; Jorge-Alberto Nagles-Pelaez; Wilmar-Arley Maya-Salazar; Jorge Madrid; Maria-Angelica Maya-Restrepo; Rodrigo-Alberto Agudelo-Pérez; Jesús Ochoa


Infectio | 2011

Epidemiología de la leptospirosis en una zona andina de producción pecuaria.

Jesús Ochoa; Antonio Sánchez; Iván Ruiz


Infectio | 2011

Esterococo resistente a vancomicina

Sigilfredo Ospina; Liliana Franco; Jaime Robledo; Lázaro A. Vélez; Luz Adriana Patiño; Jesús Ochoa

Collaboration


Dive into the Jesús Ochoa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jaime Robledo

Pontifical Bolivarian University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anuj Mubayi

Arizona State University

View shared research outputs
Top Co-Authors

Avatar

Marlio Paredes

Arizona State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge